Journal of Antimicrobial Chemotherapy (2000) 46, 146-148
© 2000 The British Society for Antimicrobial Chemotherapy
Correspondence |
The effect of banning avoparcin on VRE carriage in The Netherlands
University Hospital Maastricht, Medical Microbiology, PO Box 5800, 6202 AZ Maastricht, The Netherlands
Sir,
Acquired resistance against antibiotics is closely related to the amount of drug used, a fact observed ever since these agents were introduced into human and veterinary medicine. However, the rate of development of resistance appears to have accelerated in the past decade. In animals, antibiotics are not only used for therapy and prevention of bacterial infections, but are also added to animal feed to act as growth promoters. In some countries, antibiotic use for growth promotion is
Notes
References
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  M. Sorum, P. J. Johnsen, B. Aasnes, T. Rosvoll, H. Kruse, A. Sundsfjord, and G. S. Simonsen Prevalence, Persistence, and Molecular Characterization of Glycopeptide-Resistant Enterococci in Norwegian Poultry and Poultry Farmers 3 to 8 Years after the Ban on Avoparcin Appl. Envir. Microbiol., January 1, 2006; 72(1): 516 - 521. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. J. Johnsen, J. I. Osterhus, H. Sletvold, M. Sorum, H. Kruse, K. Nielsen, G. S. Simonsen, and A. Sundsfjord Persistence of Animal and Human Glycopeptide-Resistant Enterococci on Two Norwegian Poultry Farms Formerly Exposed to Avoparcin Is Associated with a Widespread Plasmid-Mediated vanA Element within a Polyclonal Enterococcus faecium Population Appl. Envir. Microbiol., January 1, 2005; 71(1): 159 - 168. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. H. T. Wagenvoort, D. M. T. Burgers, T. H. C. Wagenvoort, and E. Burgers Absence of vancomycin-resistant enterococci (VRE) in companion dogs in the conurbation of Parkstad Limburg, The Netherlands J. Antimicrob. Chemother., September 1, 2003; 52(3): 532 - 532. [Full Text] [PDF]
|
|
|
|
|
|
M. Casewell, C. Friis, E. Marco, P. McMullin, and I. Phillips The European ban on growth-promoting antibiotics and emerging consequences for human and animal health J. Antimicrob. Chemother., August 1, 2003; 52(2): 159 - 161. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Ridwan, E. Mascini, N. van der Reijden, J. Verhoef, and M. Bonten What action should be taken to prevent spread of vancomycin resistant enterococci in European hospitals? BMJ, March 16, 2002; 324(7338): 666 - 668. [Full Text] [PDF]
|
|
|
|
 |
|
 D. Barber, G. Miller, P. McNamara, P. Sundberg, L. P. Vogel, B. T. Blackman, D. G. White, P. F. McDermott, J. Meng, L. C. McDonald, et al. Resistant Bacteria in Retail Meats and Antimicrobial Use in Animals N. Engl. J. Med., March 7, 2002; 346(10): 777 - 779. [Full Text] [PDF]
|
|
|
|
 |
|
 A. E. van den Bogaard, M. Hazen, M. Hoyer, P. Oostenbach, and E. E. Stobberingh Effects of Flavophospholipol on Resistance in Fecal Escherichia coli and Enterococci of Fattening P Antimicrob. Agents Chemother., January 1, 2002; 46(1): 110 - 118. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. M. Aarestrup, A. M. Seyfarth, H.-D. Emborg, K. Pedersen, R. S. Hendriksen, and F. Bager Effect of Abolishment of the Use of Antimicrobial Agents for Growth Promotion on Occurrence of Antimicrobial Resistance in Fecal Enterococci from Food Animals in Denmark Antimicrob. Agents Chemother., July 1, 2001; 45(7): 2054 - 2059. [Abstract] [Full Text] [PDF]
|
|